Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006

Acta Oncologica

Volumn 49, Issue 5, 2010, Pages 694-712

  Storm, Hans H ^a   Klint, Åsa ^b   Tryggvadóttir, Laufey ^c,d   Gislum, Mette ^a   Engholm, Gerda ^a   Bray, Freddie ^e,f   Hakulinen, Timo ^g  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^c ICELANDIC CANCER REGISTRY   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

^e Cancer Registry of Norway ^*  (Norway)

^f UNIVERSITY OF OSLO   (Norway)

^g FINNISH CANCER REGISTRY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; COMORBIDITY; DENMARK; FINLAND; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; ICELAND; LEUKEMIA; LIFESTYLE; LYMPHOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NORWAY; POPULATION RESEARCH; PRIORITY JOURNAL; SWEDEN; TREND STUDY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DENMARK; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HODGKIN DISEASE; HUMANS; ICELAND; INCIDENCE; LEUKEMIA; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; MULTIPLE MYELOMA; NEOPLASM STAGING; NORWAY; REGISTRIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; SWEDEN;

EID: 77952799758     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841861003631495     Document Type: Article

References (20)

1. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint Å, et al. NORDCAN: Cancer incidence, mortality and prevalence in the Nordic countries, Version 3.4. Association of Nordic Cancer Registries. Danish Cancer Society. 2009 Available from http://www.ancr.nu.
2. Hartge P, Wang SS, Bracci PM, Devesa SS, Holly EA. Non- Hodgkin lymphoma. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. pp. 898-918.
3. Ekström-Smedby K. Epidemiology and etiology of non- Hodgkin lymphoma-a review. Acta Oncol 2006;45:258-271
4. Mueller NE, Grufferman S. Hodgkin lymphoma. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. pp. 872-897
5. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R; the EUROCARE Working Group. EUROCARE- 4. Survival of cancer patients diagnosed in 1995- 1999. Results and commentary. Eur J Cancer 2009;45: 931-991
6. Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, et al. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries. APMIS Suppl. 1995;49:1-161.
7. Møller B, Fekjaer H, Hakulinen T, Tryggvadóttir L, Storm HH, Talbäck M et al. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev 2002;11(Suppl 1):S1-S96.
8. Roos AJ, Baris D, Weiss NS, Herrington L. Multiple myeloma. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. pp. 919-945
9. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al., editors. Cancer incidence in five continents. Vol IX, Lyon, France: IARC Scientific Publications 160; 2007.
10. Linet M, Devesa SS, Morgan GJ. The leukemias. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention 3rd ed. New York: Oxford University Press; 2006. pp. 841-871
11. Engholm G, Storm HH, Ferlay J, Christensen N, Bray F, Ólafsdóttir E, et al. NORDCAN: Cancer incidence and mortality in the Nordic countries Acta Oncol 2010.
12. Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up the end of 2006. Material and methods. Acta Oncol; 2010.
13. Brenner H, Rachet B. Hybrid analysis for up-to-date longterm survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 2004;40:2494-2501
14. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307-2316
15. Talbäck M, Rosén M, Stenbeck M, Dickman PW. Cancer patient survival in Sweden at the beginning of the third millennium-predictions using period analysis. Cancer Causes Control 2004;15:967-976
16. Nordic Myelomatosis Study Group. Nordic reference programme on Myelomaosis diagnosis and treatment 2001. Cited 30.11.2009. Available from http://www.nordic-myeloma.org/content/dk/pdf/ referenceprogrammer/ referenceprogram- 2001.pdf.
17. Smith A, Wisloff F, Samson D. Guide on the diagnostics and management of multiple myeloma 2005. Br J Haematol 2005;132:410-451
18. Lund EM, Clemmensen IH, Storm HH, Engholm G. Survey of the Nordic Cancer Registries, Danish Cancer Society, Copenhagen 2000. Available from http://www.ncu.nu/ancr/ pdf/survey.pdf 29-08-2009.
19. Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27-33.
20. Thygesen LC, Nielsen OJ, Johansen C. Trends in adult leukaemia incidence and survival in Denmark, 1943-2003. Cancer Causes Control 2009;20:1671-1680